DK Life Science Co., Ltd. (303810.KQ)
KOSDAQ · KRW · Healthcare · Medical Instruments & Supplies
₩2,280 (+0.00%) as of
Key statistics
- Market cap
- 72.92B
- Dividend yield
- 0.00%
- 52-week range
- 2,155.00 – 4,110.00
- Revenue (TTM)
- 117.75B
- Profit margin
- 4.22%
- Volume
- 63.53k
About DK Life Science Co., Ltd.
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.